Generate a tailored SOP for Dr. Christopher Counter. Improve your application with a focused, well-structured draft.
Christopher M. Counter is the George Barth Geller Distinguished Professor in the Department of Pharmacology and Cancer Biology at Duke University. His research focuses on molecular mechanisms that underlie the onset of human cancers, with the goal of preventing cancer initiation and progression. The Counter lab utilizes ultra-sensitive sequencing platforms and proteomic-coupled CRISPR/Cas9 screens to elucidate factors that influence mutational patterns during the initiation of tumorigenesis. Christopher completed his Ph.D. at McMaster University in 1996 and has a Bachelor of Science from the same institution. His past appointments include roles as Associate Professor and Assistant Professor in Pharmacology and Cancer Biology at Duke University. He has received various grants to study targets in cancer, particularly focusing on oncoproteins in rhabdomyosarcoma and other cancer research initiatives.
Duke University • Durham, NC
Professor in the Department of Pharmacology and Cancer Biology.
Duke University • Durham, NC
Held a faculty position in the Department of Pharmacology and Cancer Biology.
Duke University • Durham, NC
Conducted research and taught in the Department of Pharmacology and Cancer Biology.
Duke University • Durham, NC
Worked on cancer research initiatives in the Department of Radiation Oncology.
Duke University • Durham, NC
Temporary instructor position in the Department of Pharmacology and Cancer Biology.
Department of Biomedical Engineering (MS program)